Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Impact of Photodynamic Diagnosis on Immune Cell Infiltration in BCG-treated Non–muscle-invasive Bladder Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-A summary of the 2024 guidelines update
10.1016/j.eururo.2024.07.027 · 2024 · External reference
Hexaminolevulinate in the management of nonmuscle invasive bladder cancer: a meta-analysis
2019 · External reference
Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis
10.1136/bmjopen-2018-028173 · 2019 · External reference
Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis
10.1111/bju.16364 · 2024 · External reference
Performance of narrow band imaging (NBI) and photodynamic diagnosis (PDD) fluorescence imaging compared to white light cystoscopy (WLC) in detecting non-muscle invasive bladder cancer: a systematic review and lesion-level diagnostic meta-analysis
10.3390/cancers13174378 · 2021 · External reference
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis
10.1017/s0266462310001364 · 2011 · External reference
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data
10.1016/j.eururo.2013.03.059 · 2013 · External reference
Bladder cancer
10.1038/s41572-023-00468-9 · 2023 · External reference
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
10.1038/s41585-018-0055-4 · 2018 · External reference
The mechanism of action of BCG therapy for bladder cancer–a current perspective
10.1038/nrurol.2014.15 · 2014 · External reference
Antitumor effect and induced immune response following exposure of hexaminolevulinate and blue light in combination with checkpoint inhibitor in an orthotopic model of rat bladder cancer
10.3390/biomedicines10030548 · 2022 · External reference
Immune contexture changes following blue light cystoscopy with hexaminolevulinate in bladder cancer
10.1016/j.euros.2023.10.007 · 2023 · External reference
Intravesical anti-PD-1 immune checkpoint inhibition treats urothelial bladder cancer in a mouse model
10.1097/ju.0000000000001576 · 2021 · External reference
Elevated T-cell exhaustion and urinary tumor DNA levels are associated with Bacillus Calmette-Guérin failure in patients with non-muscle-invasive bladder cancer
10.1016/j.eururo.2022.09.008 · 2022 · External reference
Expression of PD-1 and PD-L1 in BCG-treated NMIBC
10.1177/23523735251368683 · 2025 · External reference
TNF/TNFR superfamily members in costimulation of T cell responses-revisited
10.1146/annurev-immunol-082423-040557 · 2025 · External reference
Gene expression markers of Tumor Infiltrating leukocytes
10.1186/s40425-017-0215-8 · 2017 · External reference
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – a target for novel cancer therapy
10.1016/j.ctrv.2017.11.007 · 2018 · External reference
The multiple faces of CCL13 in immunity and inflammation
10.1007/s10787-013-0177-5 · 2013 · External reference
The VEGF/VEGFR axis revisited: implications for cancer therapy
10.3390/ijms232415585 · 2022 · External reference
T cell exhaustion
10.1038/ni.2035 · 2011 · External reference
Photodynamic therapy for bladder cancers, a focused review†
10.1111/php.13726 · 2023 · External reference
Photodynamic diagnosis and therapy in non-muscle-invasive bladder cancer
10.3390/cancers16132299 · 2024 · External reference
